课题基金 / 基金详情

Establishment of new molecular therapy of keloid and elucidation of mechanism of development by IL-23/IL-17 pathway

Establishment of new molecular therapy of keloid and elucidation of mechanism of development by IL-23/IL-17 pathway
瘢痕疙瘩新分子疗法的建立及IL-23/IL-17通路发展机制的阐明
批准号:
21592298
负责人:
TOSA Mamiko
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

TOSA Mamiko的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经报道了IL-6介导的炎症是一个关键的参与者,可能被认为是瘢痕疙瘩发展的一个共同的致病因素。IL-17是一种最近发现的促炎细胞因子,由一种被称为Th17的活化CD4 t细胞的独特亚型分泌。我们首先检测了患者外周血和瘢痕组织中Th17细胞的分布。与正常人相比,Th17细胞的数量有所增加。IL-17基因在瘢痕疙瘩源性成纤维细胞(KF)中的表达高于正常真皮源性成纤维细胞(NF)。在加入IL-17A肽后的NF培养物中,以及在不同浓度的抗IL-17抗体抑制IL-17后的KF培养物中,我们测量了两种主要ECM分子COL1A2和FN1的mRNA表达。在NF培养基中添加IL-17A可显著且剂量依赖地增强COL1A2和FN1 mRNA的表达,而在KF培养基中使用抗IL-17抗体抑制IL-17可降低COL1A2和FN1 mRNA的表达。我们的研究结果表明,IL-17信号可能在瘢痕疙瘩的发病机制中起着不可或缺的作用,并为开发IL-17阻断策略来治疗或预防瘢痕疙瘩提供了线索。
英文摘要
We have reported that IL-6 mediated inflammation is a key player and may be considered as a common causative factor for development of keloid. IL-17, a recently discovered pro-inflammatory cytokine, is secreted by a distinct subtype of activated CD4 T-cells known as Th17.We first examined the distribution of Th17 cells in peripheral blood and keloid tissues obtained from the patients. There was an increased in Th17 cells as compared with normal individuals. The expression of IL-17 gene in keloid derived fibroblasts(KF) was higher than in normal dermis derived fibroblasts(NF). We measured mRNA expressions of two principal ECM molecules, COL1A2 and FN1, in NF cultures after addition of IL-17A peptide or in KF cultures after inhibition of IL-17 with anti-IL-17 antibody at various concentrations. Addition of IL-17A in NF culture medium significantly and dose-dependently enhanced COL1A2 and FN1 mRNA expressions, whereas inhibition of IL-17 by anti-IL-17 antibody in KF culture medium lowered COL1A2 and FN1 mRNA expressions. Our results indicate that IL-17 signaling may play an integral role in keloid pathogenesis and provide clues for development of IL-17 blocking strategies for therapy or prophylaxis of keloid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ケロイドにおけるTh17細胞のIL-6シグナル促進効果の検討
Th17细胞在瘢痕疙瘩中IL-6信号促进作用的检测
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [土佐眞美子, モハマッド・ガジザデ]
通讯作者: モハマッド・ガジザデ
Establishment of novel molecular target therapy and determination of developmental mechanism of keloid by inhibition of IL-6 signaling
  • 批准号:
    18591973
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.62万
  • 财政年份:
    2006
  • 负责人:
    TOSA Mamiko
  • 依托单位:
Molecular biological analysis of the Wnt signal pathway in keloid development
  • 批准号:
    15591906
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2003
  • 负责人:
    TOSA Mamiko
  • 依托单位:
国内基金
海外基金
IL-23/IL-17轴介导糖尿病视网膜病变的炎症反应及作用机制研究
巨噬细胞Piezo1通过Ca2+调控自噬介导IL-23/IL-17在肺血栓栓塞症炎症反应中的作用机制研究
  • 批准号:
    82470046
  • 项目类别:
    面上项目
  • 资助金额:
    48.50万元
  • 批准年份:
    2024
  • 负责人:
    张竹
  • 依托单位:
靶向 IL-17,IL-23 和 TNF-α的新型三特异性 抗体在银屑病体内外模型中的作用及机制研 究
土家药血筒抑制IL-23/IL-17/NF-κB通路抗RA骨破坏药效作用机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    余黄合
  • 依托单位: